In breast cancer, the downregulation of CX43 significantly promoted tumor progression, while overexpression of CX43 could suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential, suggesting that CX43 can function as a tumor suppressor [3]. This evidence concerns the gene GJA1 and breast carcinoma.